Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: a question ,when we shook hands again with TPL feb 03, statement said

The PR says: "increased involvement of Patriot in the oversight of the MMP Portfolio activities"

I believe this means that TPL cannot sign a license agreement without PTSC's approval. I don't believe this effects the language of the MA/Operating Agreement/ComAg (whichever applies) whereby PTSC is still required to get approval from TPL before releasing information.

As always, corrections welcome

Share
New Message
Please login to post a reply